Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia
About this item
Full title
Author / Creator
Publisher
Netherlands: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Hypoxia-induced pulmonary arterial hypertension (HPAH) is a refractory disease characterized by increased proliferation of pulmonary vascular smooth cells and progressive pulmonary vascular remodeling. The level of nitric oxide (NO), a potential therapeutic vasodilator, is low in PAH patients. L-arginine can be converted to either beneficial NO by...
Alternative Titles
Full title
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1760864680
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1760864680
Other Identifiers
ISSN
0300-8177
E-ISSN
1573-4919
DOI
10.1007/s11010-015-2611-z
